Medicus Pharma Ltd. (MDCX) — Institutional Holders, Q2 2026
27 institutional investment managers reported a MDCX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.2M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
MDCX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- JANE STREET GROUPNew · +333,673 sh+$148.9K
- XTX Topco LtdNew · +243,362 sh+$108.6K
- Sterling Investment Advisors, Ltd.New · +100,000 sh+$44.6K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPNew · +31,462 sh+$14.0K
- STIFEL FINANCIALNew · +30,000 sh+$13.4K
Biggest sellers
- Private Advisor GroupSold out · -289,055 sh-$129.0K
- Virtu FinancialSold out · -74,045 sh-$33.0K
- UBS Group AGTrimmed · -39,703 sh-$17.7K
- BlackRockSold out · -37,294 sh-$16.6K
- Wilmington Savings Fund Society, FSBTrimmed · -25,622 sh-$11.4K
MDCX 13F holders ranked 1–27 of 27
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Interchange Capital Partners#1 · 1,586,871 sh | 1,586,871 | $718.4K | 0.14% | -4.5% |
| 2 | JANE STREET GROUP#2 · 333,673 sh | 333,673 | $148.9K | 0.00% | New |
| 3 | XTX Topco Ltd#3 · 243,362 sh | 243,362 | $108.6K | <0.01% | New |
| 4 | Sterling Investment Advisors, Ltd.#4 · 100,000 sh | 100,000 | $44.6K | — | New |
| 5 | ARMISTICE CAPITAL#5 · 60,600 sh | 60,600 | $39.4K | <0.01% | 0.0% |
| 6 | COMMONWEALTH EQUITY SERVICES#6 · 52,643 sh | 52,643 | $23.5K | 0.00% | +9.3% |
| 7 | May Hill Capital#7 · 50,622 sh | 50,622 | $22.6K | <0.01% | 0.0% |
| 8 | Anson Funds Management#8 · 42,400 sh | 42,400 | $18.9K | <0.01% | 0.0% |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#9 · 31,462 sh | 31,462 | $14.0K | 0.00% | New |
| 10 | STIFEL FINANCIAL#10 · 30,000 sh | 30,000 | $13.4K | 0.00% | New |
| 11 | JPMORGAN CHASE#11 · 25,622 sh | 25,622 | $12.5K | 0.00% | New |
| 12 | Wilmington Savings Fund Society, FSB#12 · 25,622 sh | 25,622 | $11.4K | — | -50.0% |
| 13 | CITADEL ADVISORS#13 · 25,102 sh | 25,102 | $11.2K | 0.00% | +40.8% |
| 14 | Smithfield#14 · 24,614 sh | 24,614 | $11.0K | <0.01% | +114.4% |
| 15 | Stratos Wealth Partners, LTD.#15 · 20,950 sh | 20,950 | $9.3K | <0.01% | New |
| 16 | LPL Financial#16 · 17,512 sh | 17,512 | $7.8K | 0.00% | +12.2% |
| 17 | MARATHON CAPITAL MANAGEMENT#17 · 15,500 sh | 15,500 | $6.9K | — | 0.0% |
| 18 | StoneX Group#18 · 17,066 sh | 17,066 | $6.4K | <0.01% | +12.5% |
| 19 | Foundations Investment Advisors#19 · 11,000 sh | 11,000 | $4.9K | <0.01% | New |
| 20 | Connective Capital Management#20 · 6,000 sh | 6,000 | $3.9K | <0.01% | 0.0% |
| 21 | OSAIC#21 · 7,500 sh | 7,500 | $3.4K | 0.00% | -11.8% |
| 22 | UBS Group AG#22 · 2,203 sh | 2,203 | $1.4K | 0.00% | -94.7% |
| 23 | MORGAN STANLEY#23 · 1,022 sh | 1,022 | $456.00 | 0.00% | -81.3% |
| 24 | JONES FINANCIAL COMPANIES LLLP#24 · 400 sh | 400 | $183.00 | 0.00% | 0.0% |
| 25 | WELLS FARGO & COMPANY#25 · 200 sh | 200 | $89.00 | 0.00% | +166.7% |
| 26 | ROYAL BANK OF CANADA#26 · 1,055 sh | 1,055 | $0.00 | 0.00% | New |
| 27 | HAZLETT, BURT & WATSON#27 · 425 sh | 425 | $0.00 | 0.00% | 0.0% |
Funds that sold out of MDCX in Q2 2026 (7)
Held MDCX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Private Advisor Group289,055 sh | 289,055 | $137.6K |
| Virtu Financial74,045 sh | 74,045 | $34.0K |
| BlackRock37,294 sh | 37,294 | $17.1K |
| Empery Asset Management12,100 sh | 12,100 | $11.5K |
| TWO SIGMA SECURITIES15,617 sh | 15,617 | $7.2K |
| BRAVE ASSET MANAGEMENT10,000 sh | 10,000 | $4.6K |
| Tower Research Capital (TRC)121 sh | 121 | $56.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.